| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |